| RS2116842824 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS2116852322 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116854694 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS2116854732 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116855121 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116855161 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116855176 |
CLCN1
|
Health Risk |
Pathogenic |
— |
| RS2116864878 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116865174 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116880438 |
SGCE
|
Health Risk |
Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116880447 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116880537 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116880618 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116881189 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116881481 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116881558 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116882157 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116882526 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116916386 |
SEMA3E
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1A, SEMA3E-related disorder |
| RS2116916717 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS2116917246 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116917821 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116918021 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116920835 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS2116921218 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116924115 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS2116928557 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiac arrhythmia |
| RS2116928626 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS2116928723 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116928923 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116929283 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116929916 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116929974 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2116930765 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116931511 |
KCNH2
|
Health Risk |
Likely pathogenic |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2116931753 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116933379 |
KCNH2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Long QT syndrome |
| RS2116933757 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS2116933842 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS2116937449 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116937500 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116937619 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116939192 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116939236 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116939333 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116939424 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116940231 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116940243 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116940397 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116940777 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116941701 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS211694394 |
VPS37A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 53, Hereditary spastic paraplegia 53 |
| RS2116950615 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2116950992 |
KCNH2
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Long QT syndrome |
| RS2116954362 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116954409 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116954443 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116954525 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2116955668 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS2116958989 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116959244 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116960034 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS2116960125 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116960605 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116960647 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116960827 |
KCNH2
|
Health Risk |
Pathogenic |
Congenital long QT syndrome, Congenital long QT syndrome |
| RS2116961210 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2116962569 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116963916 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiac arrhythmia |
| RS2116964263 |
KCNH2
|
Health Risk |
Pathogenic |
Short QT syndrome type 1, Long QT syndrome 2 |
| RS2116964889 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116969765 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116971722 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116971776 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116972508 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116972578 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116972912 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116987965 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2116989385 |
VPS50
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS2116992551 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS2116992583 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS2116997026 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS2116998520 |
AGK
|
Health Risk |
Pathogenic |
Cataract 38, Sengers syndrome |
| RS2116998812 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2116999316 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117003430 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117003707 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117003824 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS2117005326 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117006178 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS2117006599 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117007319 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117011246 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2117011733 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS2117011793 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS2117011952 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS2117015674 |
ASAH1
|
Health Risk |
Pathogenic |
— |
| RS2117018589 |
ASAH1
|
Health Risk |
Pathogenic |
ASAH1-related disorders, ASAH1-related disorders |
| RS2117019094 |
ASAH1
|
Health Risk |
Likely pathogenic |
— |
| RS2117021067 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |